The Medicine Maker | The Medicine Maker

How Genomics Is Personalizing Drug Discovery

October 20, 2026

Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention

4 min read

Outsourcing

Bioprocessing

Development & Clinical

Interviews

Technology & Manufacturing

Choosing a Sterile Fill-Finish Partner

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

Drug Delivery

Formulation

Facilities & Equipment

Interviews

Technology & Manufacturing

Meeting the Demands of Injectable Drug Delivery

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

Industry News

Can Clinical Trials Collect Less Data Without Compromising Safety?

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

Research News

CAR NK Cells Target Cancer and Autoimmunity

mRNA nanoparticles reprogram NK cells in vivo, inducing tumor remissions and reducing autoimmune liver damage in mice.

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Cell & Gene Research News

Prime Editing Corrects GATA2 Deficiency in Patient Stem Cells

October 21, 2026

The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice

2 min read

Drug Discovery Development & Clinical Interviews

How Genomics Is Personalizing Drug Discovery

October 20, 2026

Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention

4 min read

Drug Discovery Biopharma Interviews Business & Trends Technology & Manufacturing Power List

Musings from The Power List: Piers Ingram

October 20, 2026

Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines

4 min read

Cell & Gene Research News

Gene Therapy Approach Shows Promise for Hydrocephalus

October 20, 2026

Researchers develop AAV-based method to target cerebrospinal fluid production, revealing new insights into postnatal neurogenesis

2 min read

Facilities & Equipment Sponsored

Inside Kindeva’s New Sterile Fill-Finish Facility

October 20, 2026

John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner

5 min read

Packaging Standards & Regulation Technology & Manufacturing Sponsored

Making Clinical Trial Labels More Accessible

October 19, 2026

Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information

5 min read

Cell & Gene Research News

SRSF1 Gene Delivery Extends Lifespan in Aged Mice

October 19, 2026

An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of cellular aging without erasing cell identity

2 min read

Cell & Gene Technology & Manufacturing Research News

Three Targets, One CAR T Therapy

October 19, 2026

First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma

3 min read

Business & Trends

Hiring for What Comes Next

October 19, 2026

Biotech boards are looking beyond big names to find leaders with the experience and flexibility to handle the company’s next major challenge.

6 min read

Biopharma Interviews Business & Trends Sitting Down With

Video: Building the Airplane While Flying It – with Jonny Wray

October 16, 2026

Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology

1 min read

Top Stories